These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682 [TBL] [Abstract][Full Text] [Related]
24. Surveillance on mutation carriers of DNA mismatch repair genes. Järvinen HJ; Aarnio M Ann Chir Gynaecol; 2000; 89(3):207-10. PubMed ID: 11079789 [TBL] [Abstract][Full Text] [Related]
25. A proven de novo germline mutation in HNPCC. Kraus C; Kastl S; Günther K; Klessinger S; Hohenberger W; Ballhausen WG J Med Genet; 1999 Dec; 36(12):919-21. PubMed ID: 10594000 [TBL] [Abstract][Full Text] [Related]
26. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993 [TBL] [Abstract][Full Text] [Related]
27. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
28. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. Lindor NM; Petersen GM; Hadley DW; Kinney AY; Miesfeldt S; Lu KH; Lynch P; Burke W; Press N JAMA; 2006 Sep; 296(12):1507-17. PubMed ID: 17003399 [TBL] [Abstract][Full Text] [Related]
29. N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Heinimann K; Scott RJ; Chappuis P; Weber W; Müller H; Dobbie Z; Hutter P Cancer Res; 1999 Jul; 59(13):3038-40. PubMed ID: 10397239 [TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in human solid tumors. Lothe RA Mol Med Today; 1997 Feb; 3(2):61-8. PubMed ID: 9060003 [TBL] [Abstract][Full Text] [Related]
31. [Mutation of human mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) families]. Yuan Y; Huang J; Zheng S Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):105-7. PubMed ID: 11776847 [TBL] [Abstract][Full Text] [Related]
32. Molecular genetics and endometrial cancer. Lalloo F; Evans G Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):355-63. PubMed ID: 11476558 [TBL] [Abstract][Full Text] [Related]
33. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer. Vasen HF; Wijnen J Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704 [No Abstract] [Full Text] [Related]
34. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nicolaides NC; Papadopoulos N; Liu B; Wei YF; Carter KC; Ruben SM; Rosen CA; Haseltine WA; Fleischmann RD; Fraser CM Nature; 1994 Sep; 371(6492):75-80. PubMed ID: 8072530 [TBL] [Abstract][Full Text] [Related]
35. [Molecular diagnosis and clinical consequences in families with HNPCC syndrome]. Pistorius S; Plaschke J; Kruppa C; Rüschoff J; Nagel M; Saeger HD; Schackert HK Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):293-7. PubMed ID: 14518263 [TBL] [Abstract][Full Text] [Related]
37. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Collins V; Meiser B; Gaff C; St John DJ; Halliday J Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171 [TBL] [Abstract][Full Text] [Related]
38. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online. Holmberg M; Kristo P; Chadwicks RB; Mecklin JP; Järvinen H; de la Chapelle A; Nyström-Lahti M; Peltomäki P Hum Mutat; 1998; 11(6):482. PubMed ID: 10200055 [TBL] [Abstract][Full Text] [Related]
39. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. Watson P; Narod SA; Fodde R; Wagner A; Lynch JF; Tinley ST; Snyder CL; Coronel SA; Riley B; Kinarsky Y; Lynch HT J Med Genet; 2003 Aug; 40(8):591-6. PubMed ID: 12920070 [TBL] [Abstract][Full Text] [Related]
40. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Jones JS; Chi X; Gu X; Lynch PM; Amos CI; Frazier ML Clin Cancer Res; 2004 Sep; 10(17):5845-9. PubMed ID: 15355915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]